The Bridgepoint share price soars on market debut. Is this the 2021 IPO stock to buy?

The record of flotations on the UK stock market is peppered with failures. But the Bridgepoint share price has bucked that trend.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Bridgepoint (LSE: BPT) announced an IPO offer price of 350p a share on 21 July. Since then, the Bridgepoint share price climbed to 495p by market close on 26 July. That’s a 40% gain in just a few days, the kind of thing IPO dreams are made of. Eat your heart out, Aston Martin.

But is it going to be a flash in the pan, or the start of something big? And should I buy shares on the open market now? Before I can decide that, I need to take a look at what the company does.

Bridgepoint is a private equity group. It describes itself as “an international alternative asset fund management group focussing on the Middle Market.” That, it says, consists of “investing in market-leading businesses typically valued between €200 million and €1.5 billion.”

There are other segments in the firm’s portfolio, but that’s the core of it. And with €27bn in funds under management, it seems there are plenty of wealthy individuals who like Bridgepoint’s approach. It’s clearly starting public life as a successful company, rather than as a speculative chancer coming to market in need of cash. And that’s presumably the driver behind the early Bridgepoint share price spike.

Why might I buy?

As a small private investor, what might be the attraction for me? Well, it’s sort of a way to gain exposure to private equity markets. That doesn’t mean I’d get to invest in such assets directly, but that’s fine. I’d never hand over my money to a fund manager to invest for me anyway. But buying Bridgepoint shares would get me a cut of the profits the company makes in fees from investing rich people’s cash. And I do like that.

In fact, I’m keen on the idea of investing in asset managers generally. And I’ve come close to buying Man Group shares on more than one occasion. The Man share price has had an erratic five years, though. But the company has been paying decent dividends.

Bridgepoint share price volatility?

Might the Bridgepoint share price be volatile too? Well, its underlying investments, in private rather than publicly-quoted companies, could offer an advantage. Those companies don’t have hordes of short-term investors hanging on their daily share price movements. They don’t even have share prices. So Bridgepoint should be under less pressure to trade, from investing institutions that look no further than the next quarter’s figures.

Short-term volatility wouldn’t put me off, mind. As billionaire investor Warren Buffett suggests, I wouldn’t consider buying Bridgepoint shares unless I was prepared to hold them for at least 10 years.

So I do see the attractions of Bridgepoint. But whenever I want to put some money into an asset manager, I’ve always gone for an investment trust. Doing that gets me a direct share in the underlying assets. I don’t think I’ll move away from that strategy, but I will be watching where the Bridgepoint share price goes next.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »